| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 12/16/2010 | WO2010142457A1 Semi-solid compositions and pharmaceutical products |
| 12/16/2010 | WO2010142456A1 Solid compositions comprising 5-aminolevulinic acid |
| 12/16/2010 | WO2010142400A2 Chitosan oligosaccharide-based compositions |
| 12/16/2010 | WO2010142284A2 Arrangement for the remote-controlled release of active substances |
| 12/16/2010 | WO2010142276A1 Sleep mask/eye cover and method for producing the same |
| 12/16/2010 | WO2010142183A1 Pharmaceutical composition for treatment of type 2 diabetes in mammals including human beings |
| 12/16/2010 | WO2010142182A1 Pharmaceutical composition for treatment of type 2 diabetes in mammals including human beings |
| 12/16/2010 | WO2010122574A3 Coated capsule |
| 12/16/2010 | WO2010100656A3 Storage stable prostaglandin product |
| 12/16/2010 | WO2010060886A3 Mouthwash in the form of a stable suspension comprising microspheres that incorporate an active ingredient |
| 12/16/2010 | WO2010007252A3 Formulation for improving the bioavailability of a hydrophobic molecule |
| 12/16/2010 | WO2009148579A3 Dehydrated hydrogel inclusion complex of a bioactive agent with flowable drug delivery system |
| 12/16/2010 | WO2009143841A8 Film-coated compressed chewing gum |
| 12/16/2010 | US20100318025 Programmable medical drug delivery systems and methods for delivery of multiple fluids and concentrations |
| 12/16/2010 | US20100317631 Gel Composition and Transcrotal Application of a Composition for the Treatment of Hypogonadism |
| 12/16/2010 | US20100317609 Method of Producing Hydroxyalkyl Starch Derivatives |
| 12/16/2010 | US20100317586 Method for topical treatment of eye disease and composition and device for said treatment |
| 12/16/2010 | US20100316795 Polyamide-based powder and its use for obtaining an antibacterial coating |
| 12/16/2010 | US20100316740 Compositions for the treatment of benign prostate hypertrophy, prostatitis, prostatosis and prostate cancer |
| 12/16/2010 | US20100316726 Tooth sealant |
| 12/16/2010 | US20100316725 Reduction of flake-like aggregation in nanoparticulate active agent compositions |
| 12/16/2010 | US20100316724 Composition |
| 12/16/2010 | US20100316723 Compositions and methods for treating inflammation |
| 12/16/2010 | US20100316722 Pharmaceutical Forms for the Release of Active Compounds |
| 12/16/2010 | US20100316721 Granular Sustained Release Preparation and Production Thereof |
| 12/16/2010 | US20100316720 Use of an extract from snow algae in cosmetic or dermatological formulations |
| 12/16/2010 | US20100316719 B-1,3-glucan-derived polyaldehyde/polyamine hydrogel |
| 12/16/2010 | US20100316718 Activated foam |
| 12/16/2010 | US20100316717 Injectable hydrogel microspheres from aqueous two-phase system |
| 12/16/2010 | US20100316716 Method for treating herpes zoster lesions |
| 12/16/2010 | US20100316715 Chitosan composition |
| 12/16/2010 | US20100316714 Methods of treating disease with random copolymers |
| 12/16/2010 | US20100316713 Pharmaceutical composition |
| 12/16/2010 | US20100316712 Pharmaceutical compositions for treatment of parkinson's disease and related disorders |
| 12/16/2010 | US20100316711 Nifedipine containing opress coated tablet and method of preparing same |
| 12/16/2010 | US20100316710 Sustained-release tablet composition of pramipexole |
| 12/16/2010 | US20100316709 Orally disintegrating solid preparation |
| 12/16/2010 | US20100316708 Novel Pharmaceutical Formulation Containing A Biguanide and a Thiazolidinedione Derivative |
| 12/16/2010 | US20100316707 Methods and compositions for enhancing delivery of double-stranded rna or a double-stranded hybrid nucleic acid to regulate gene expression in mammalian cells |
| 12/16/2010 | US20100316706 Carbocyclic and oxacarbocyclic fumaric acid oligomers |
| 12/16/2010 | US20100316705 System for exsanguinous metabolic support of an organ or tissue |
| 12/16/2010 | US20100316704 Platinum complexes and methods of use |
| 12/16/2010 | US20100316703 Rna interference mediating small rna molecules |
| 12/16/2010 | US20100316702 Compositions and methods for regulating erythropoeitin expression and ameliorating anemia and stimulating erythropoiesis |
| 12/16/2010 | US20100316701 Compositions and method for manipulating pim-1 activity in circulatory system cells |
| 12/16/2010 | US20100316700 Systemic administration of liposomal reduced glutathione for the decorporation of radioactive materials and non-radioactive mercury |
| 12/16/2010 | US20100316699 Compositions and Methods for Inhibiting Viral Replication |
| 12/16/2010 | US20100316698 Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
| 12/16/2010 | US20100316697 Methods and compositions for drug targeting |
| 12/16/2010 | US20100316696 Liposome preparation by single-pass process |
| 12/16/2010 | US20100316695 Condensation products based on bicyclic or polycyclic aromatics or heteroaromatics |
| 12/16/2010 | US20100316694 Novel filter composites for drug detoxification |
| 12/16/2010 | US20100316693 Method for preparing an antimicrobial cotton of cellulose matrix having chemically and/or physically bonded silver and antimicrobial cotton prepared therefrom |
| 12/16/2010 | US20100316692 Product and method for reducing substance craving |
| 12/16/2010 | US20100316687 Hydrophobic polysaccharides with diester- or carbonate ester-containing linkages having enhanced degradation |
| 12/16/2010 | US20100316686 Osteosynthesis with nano-silver |
| 12/16/2010 | US20100316684 Surfactant-Free Foam Formulations |
| 12/16/2010 | US20100316682 Biodegradable Hyaluronic Acid Derivative, Biodegradable Polymeric Micelle Composition and Pharmaceutical or Bioactive Composition |
| 12/16/2010 | US20100316681 N-alkylated rifampin |
| 12/16/2010 | US20100316680 Anti-inflammatory properties of marine lipid compositions |
| 12/16/2010 | US20100316679 Compositions for treating or preventing obesity and insulin resistance disorders |
| 12/16/2010 | US20100316678 Combination methods and compositions for treatment of neuropathic pain |
| 12/16/2010 | US20100316677 Use of bamboo leaf total flavones in the preparation of medicine and health food for prevention and treatment of prostatic diseases |
| 12/16/2010 | US20100316578 Oral compositions for absorption of phosphorous compounds |
| 12/16/2010 | US20100316576 Aerosols for sinunasal drug delivery |
| 12/16/2010 | US20100316571 Method and Compositions for Polymer Nanocarriers Containing Therapeutic Molecules |
| 12/16/2010 | US20100316570 Protection of Virus from Immune Cell Uptake |
| 12/16/2010 | US20100316569 Novel peptides |
| 12/16/2010 | US20100314420 Aerosol Composition |
| 12/16/2010 | CA2801842A1 Amorphous varenicline tartrate co-precipitates |
| 12/16/2010 | CA2765330A1 Reduction of opioid blood fluctuations |
| 12/16/2010 | CA2765291A1 Sublingual apomorphine |
| 12/16/2010 | CA2765233A1 Ipamorelin diacetate injection and infusion solutions |
| 12/16/2010 | CA2765172A1 Novel pharmaceutical compositions containing pregabalin |
| 12/16/2010 | CA2765156A1 Diketopiperazine microparticles with defined isomer contents |
| 12/16/2010 | CA2765033A1 Methods for treating gastrointestinal disorders |
| 12/16/2010 | CA2764828A1 Hydrophobins for dispersing active agents |
| 12/16/2010 | CA2764635A1 Topical drug delivery systems for ophthalmic use |
| 12/16/2010 | CA2764505A1 Diketopiperazine microparticles with defined specific surface areas |
| 12/16/2010 | CA2764172A1 A thrombin receptor antagonist and clopidogrel fixed dose tablet |
| 12/16/2010 | CA2764103A1 Solid dispersions containing an apoptosis-promoting agent |
| 12/16/2010 | CA2763923A1 Semi-solid compositions and pharmaceutical products |
| 12/16/2010 | CA2763837A1 Solid compositions comprising 5-aminolevulinic acid |
| 12/16/2010 | CA2763441A1 Pharmaceutical dosage form for oral administration of a bcl-2 family inhibitor |
| 12/15/2010 | EP2261296A2 Compositions comprising tetrafluoropropene and carbon dioxide |
| 12/15/2010 | EP2261263A1 Processed starch powder with excellent disintegration properties and manufacturing method thereof |
| 12/15/2010 | EP2261237A2 Daptomycin and related analogs in crystalline form, their preparation and use |
| 12/15/2010 | EP2260903A1 C-19 steroids for therapeutic uses |
| 12/15/2010 | EP2260892A2 Multireservoir implantable drug delivery pumps |
| 12/15/2010 | EP2260860A1 Calcium phosphate delivery vehicles for osteoinduktive proteins |
| 12/15/2010 | EP2260848A1 Aqueous liquid containing gatifloxacin, method for production thereof, and method for prevention of production of precipitates during storage of the aqueous liquid at low temperature or upon freezing/thawing of the aqueous liquid |
| 12/15/2010 | EP2260847A1 Aqueous liquid containing gatifloxacin |
| 12/15/2010 | EP2260845A2 Use of polyphenols for the treatment of alopecia |
| 12/15/2010 | EP2260843A2 Alpha-MSH and derivatives for the induction of tolerance against antigens |
| 12/15/2010 | EP2260837A1 Pharmaceutical compositions for the coordinated delivery of NSAIDs |
| 12/15/2010 | EP2260836A2 Rapid release tablet with coated drug-containing core and surrounding taste masking layer |
| 12/15/2010 | EP2260835A2 Composition for proteasome inhibition |
| 12/15/2010 | EP2260834A2 Granular sustained release preparation and production thereof |
| 12/15/2010 | EP2260833A2 Bilayer pharmaceutical tablet comprising telmisartan and a diuretic |
| 12/15/2010 | EP2260832A2 Optimal polymer mixtures for gastric retentive tablets |